Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10 years

Clinica Chimica Acta

Volumn 475, Issue , 2017, Pages 51-55

  Kavsak, Peter A ^a   Worster, Andrew ^a   Hill, Stephen A ^a   MacRae, Andrew R ^b   Jaffe, Allan S ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MAYO CLINIC   (United States)

Author keywords

Agreement; Analytical comparison, Stability; High sensitivity cardiac troponin

Indexed keywords

CARDIAC TROPONIN I; HEPARIN; LITHIUM HEPARIN; TROPONIN I; UNCLASSIFIED DRUG; PLASMA PROTEIN;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CARDIAC TROPONIN 1 CLIA KIT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FREEZE THAWING; IMMUNOASSAY ANALYZER; PRIORITY JOURNAL; PROTEIN DETERMINATION; SENSITIVITY ANALYSIS; BIOASSAY; BLOOD; CHEMISTRY; DEVICES; FREEZING; HUMAN; LABORATORY AUTOMATION; PLASMA; REGRESSION ANALYSIS; REPRODUCIBILITY; STANDARDS; TIME FACTOR;

AUTOMATION, LABORATORY; BIOLOGICAL ASSAY; BLOOD PROTEINS; FREEZING; HUMANS; PLASMA; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TROPONIN I;

EID: 85030977636     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2017.10.006     Document Type: Article

References (25)

1. Cullen, L.A., Mills, N.L., Mahler, S., Body, R., Early rule-out and rule-in strategies for myocardial infarction. Clin. Chem. 63 (2017), 129–139.
2. Carlton, E.W., Khattab, A., Greaves, K., Identifying patients suitable for discharge after a single-presentation high-sensitivity troponin result: a comparison of five established risk scores and two high-sensitivity assays. Ann. Emerg. Med. 66 (2015), 635–645.e1.
3. AH, Wu, Fukushima, N., Puskas, R., Todd, J., Goix, P., Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin. Chem. 52 (2006), 2157–2159.
4. Latini, R., Masson, S., Anand, I.S., Missov, E., Carlson, M., Vago, T., Angelici, L., Barlera, S., Parrinello, G., Maggioni, A.P., Tognoni, G., Cohn, J.N., Val-HeFT investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116 (2007), 1242–1249.
5. Saenger, A.K., Beyrau, R., Braun, S., Cooray, R., Dolci, A., Freidank, H., Giannitsis, E., Gustafson, S., Handy, B., Katus, H., Melanson, S.E., Panteghini, M., Venge, P., Zorn, M., Jarolim, P., Bruton, D., Jarausch, J., Jaffe, A.S., Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin. Chim. Acta 412 (2011), 748–754.
6. Hammarsten, O., Jacobsson, C.E., Widegren, M., Danylchenko, T., Jaffe, A.S., Long-time quality assessment of the Elecsys troponin T hs assay. Clin. Biochem. 46 (2013), 1055–1057.
7. Kavsak, P.A., Don-Wauchope, A.C., Hill, S.A., Worster, A., Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms. Clin. Chem. 62 (2016), 887–889.
8. Kavsak, P.A., Beattie, J., Pickersgill, R., Ford, L., Caruso, N., Clark, L., A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city. Pract. Lab. Med. 1 (2015), 28–34.
9. Lippi, G., Ferrari, A., Gandini, G., Gelati, M., Lo Cascio, C., Salvagno, G.L., Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay. Clin. Chem. Lab. Med., 2017 Jul 12, 10.1515/cclm-2017-0350 (pii: /j/cclm.ahead-of-print/cclm-2017-0350/cclm-2017-0350.xml).
10. Kavsak, P.A., MacRae, A.R., Yerna, M.J., Jaffe, A.S., Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin. Chem. 55 (2009), 573–577.
11. Kavsak, P.A., Wang, X., Ko, D.T., MacRae, A.R., Jaffe, A.S., Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin. Chem. 55 (2009), 1809–1815.
12. Kavsak, P.A., Xu, L., Yusuf, S., McQueen, M.J., High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin. Chem. 57 (2011), 1146–1153.
13. Kavsak, P.A., Hill, S.A., Bhanich Supapol, W., Devereaux, P.J., Worster, A., Biomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin. Chem. 58 (2012), 298–302.
14. Shortt, C., Phan, K., Hill, S.A., Worster, A., Kavsak, P.A., An approach to rule-out an acute cardiovascular event or death in emergency department patients using outcome-based cutoffs for high-sensitivity cardiac troponin assays and glucose. Clin. Biochem. 48 (2015), 282–287.
15. Ryan, J.B., Southby, S.J., Stuart, L.A., Mackay, R., Florkowski, C.M., George, P.M., Comparison of cardiac TnI outliers using a contemporary and a high-sensitivity assay on the Abbott Architect platform. Ann. Clin. Biochem. 51 (2014), 507–511.
16. Kavsak, P.A., Caruso, N., Beattie, J., Clark, L., Centrifugation-an important pre-analytical factor for the Abbott Architect high-sensitivity cardiac troponin I assay. Clin. Chim. Acta 436 (2014), 273–275.
17. Kavsak, P.A., Jaffe, A.S., Greene, D.N., Christenson, R.H., Apple, F.S., Total Analytic, Wu A.H.B., Error for low cardiac troponin concentrations (≤ 10 ng/l) by use of a high-sensitivity cardiac troponin assay. Clin. Chem. 63 (2017), 1043–1045.
18. Rezvanpour, A., Shortt, C., Clark, L., Worster, A., Kavsak, P.A., Analytical factors to consider when assessing a high-sensitivity cardiac troponin I assay compared to a contemporary assay in clinical studies. Clin. Chim. Acta 429 (2014), 6–7.
19. Kavsak, P., Roy, C., Malinowski, P., Mark, C.T., Scott, T., Clark, L., Lamers, S., Ainsworth, C., Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations. Ann. Clin. Biochem., 2017 Jan 1, 4563217734883 (10.1177/0004563217734883).
20. Apple, F.S., Jaffe, A.S., Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin. Chem. 58 (2012), 1599–1600.
21. Warner, J.V., Marshall, G.A., High incidence of macrotroponin I with a high-sensitivity troponin I assay. Clin. Chem. Lab. Med. 54 (2016), 1821–1829.
22. Simons, J., Beach, L., Clark, L., Kavsak, P.A., Matrix and bilirubin interference for high-sensitivity cardiac troponin I. Clin. Chim. Acta 442 (2015), 49–51.
23. Apple, F.S., Sandoval, Y., Jaffe, A.S., Ordonez-Llanos, J., IFCC task force on clinical applications of cardiac bio-markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin. Chem. 63 (2017), 73–81.
24. Kavsak, P.A., Clark, L., Jaffe, A.S., Effect of repeat measurements of high-sensitivity cardiac troponin on the same sample using the European Society of Cardiology 0-hour/1-hour or 2-hour algorithms for early rule-out and rule-in for myocardial infarction. Clin. Chem. 63 (2017), 1163–1165.
25. Masotti, S., Prontera, C., Musetti, V., Storti, S., Ndreu, R., Zucchelli, G.C., Passino, C., Clerico, A., Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I. Clin. Chem. Lab. Med., 2017 Sep 23, 10.1515/cclm-2017-0387 (pii: /j/cclm.ahead-of-print/cclm-2017-0387/cclm-2017-0387.xml).